The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.
Open accessAbstract
Apolipoprotein(a) [apo(a)] is a glycoprotein with Mr approximately equal to 280,000 that is disulfide linked to apolipoprotein B in lipoprotein(a) particles. Elevated plasma levels of lipoprotein(a) are correlated with atherosclerosis. Partial amino acid sequence of apo(a) shows that it has striking homology to plasminogen. Plasminogen is a plasma serine protease zymogen that consists of five homologous and tandemly repeated domains called kringles and a trypsin-like protease domain. The amino-terminal sequence obtained for apo(a) is homologous to the beginning of kringle 4 but not the amino terminus of plasminogen. Apo(a) was subjected to limited proteolysis by trypsin or V8 protease, and fragments generated were isolated and sequenced. Sequences obtained from several of these fragments are highly (77-100%) homologous to plasminogen residues 391-421, which reside within kringle 4. Analysis of these internal apo(a) sequences revealed that apo(a) may contain at least two kringle 4-like domains. A sequence obtained from another tryptic fragment also shows homology to the end of kringle 4 and the beginning of kringle 5. Sequence data obtained from two tryptic fragments show homology with the protease domain of plasminogen. One of these sequences is homologous to the sequences surrounding the activation site of plasminogen. Plasminogen is activated by the cleavage of a specific arginine residue by urokinase and tissue plasminogen activator; however, the corresponding site in apo(a) is a serine that would not be cleaved by tissue plasminogen activator or urokinase. Using a plasmin-specific assay, no proteolytic activity could be demonstrated for lipoprotein(a) particles. These results suggest that apo(a) contains kringle-like domains and an inactive protease domain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Proteases and biological control
Gordon, A. H. (1976) · Nature · doi:10.1038/264299a0 · Cited by 1,375
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli
Pennica, D., Holmes, W. E., Kohr, W. J., Harkins, R. N., Vehar, G. A., Ward, C. A., Bennett, W. F., Yelverton, E., Seeburg, P. H., Heyneker, H. L., et al. (1983) · Nature · doi:10.1038/301214a0 · Cited by 1,243
Self-citationHunkapiller, M. W., Lujan, E., Ostrander, F., & Hood, L. E. (1983) · Methods in Enzymology · doi:10.1016/s0076-6879(83)91019-4 · Cited by 1,105
Dahlen, G. H., Guyton, J. R., Attar, M., Farmer, J. A., Kautz, J. A., & Gotto, A. M. (1986) · Circulation · doi:10.1161/01.cir.74.4.758 · Cited by 911
The Peptide Chains of Human Plasmin
Robbins, K. C., Summaria, L., Hsieh, B., & Shah, R. J. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95967-3 · Cited by 477
Human plasma lipoprotein [a]. Structural properties.
Gaubatz, J. W., Heideman, C., Gotto, A. M., Morrisett, J. D., & Dahlen, G. H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32663-2 · Cited by 453
Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease
Berg, K., Dahlén, G., & Frick, M. H. (1974) · Clinical Genetics · doi:10.1111/j.1399-0004.1974.tb00657.x · Cited by 316
GÜNZLER, W. A., STEFFENS, G. J., ÖTTING, F., KIM, S.-M. A., FRANKUS, E., & FLOHÉ, L. (1982) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1982.363.2.1155 · Cited by 312
Binding of plasminogen to cultured human endothelial cells.
Hajjar, K. A., Harpel, P. C., Jaffe, E. A., & Nachman, R. L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67293-x · Cited by 310
Cited by
The mysteries of lipoprotein(a).
Utermann, G. (1989) · Science · doi:10.1126/science.2530631 · Cited by 1,257
Reyes-Soffer, G., Ginsberg, H. N., Berglund, L., Duell, P. B., Heffron, S. P., Kamstrup, P. R., Lloyd-Jones, D. M., Marcovina, S. M., Yeang, C., Koschinsky, M. L., et al. (2022) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000147 · Cited by 836
Hajjar, K. A., Gavishi, D., Breslow, J. L., & Nachman, R. L. (1989) · Nature · doi:10.1038/339303a0 · Cited by 702
Structure, function, and genetics of lipoprotein (a)
Schmidt, K., Noureen, A., Kronenberg, F., & Utermann, G. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067314 · Cited by 638
A potential basis for the thrombotic risks associated with lipoprotein(a)
Miles, L. A., Fless, G. M., Levin, E. G., Scanu, A. M., & Plow, E. F. (1989) · Nature · doi:10.1038/339301a0 · Cited by 583
Self-citationSorensen, K. E., Celermajer, D. S., Georgakopoulos, D., Hatcher, G., Betteridge, D. J., & Deanfield, J. E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116983 · Cited by 578
Lipoprotein (a). Heterogeneity and biological relevance.
Scanu, A. M., & Fless, G. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114625 · Cited by 573
Self-citationRosengren, A., Wilhelmsen, L., Eriksson, E., Risberg, B., & Wedel, H. (1990) · BMJ · doi:10.1136/bmj.301.6763.1248 · Cited by 539
Lipoprotein(a), fibrin binding, and plasminogen activation.
Loscalzo, J., Weinfeld, M., Fless, G. M., & Scanu, A. M. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.240 · Cited by 461
Self-citationDetection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.
Rath, M., Niendorf, A., Reblin, T., Dietel, M., Krebber, H. J., & Beisiegel, U. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.579 · Cited by 446
Lackner, C., Boerwinkle, E., Leffert, C. C., Rahmig, T., & Hobbs, H. H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115248 · Cited by 406
Transient changes of serum lipoprotein(a) as an acute phase protein
Maeda, S., Abe, A., Seishima, M., Makino, K., Noma, A., & Kawade, M. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90218-9 · Cited by 365
Hajjar, K. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116532 · Cited by 314
Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
Boffa, M. B., & Koschinsky, M. L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r060582 · Cited by 309
Wong, N. D., Budoff, M. J., Ferdinand, K., Graham, I. M., Michos, E. D., Reddy, T., Shapiro, M. D., & Toth, P. P. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100335 · Cited by 302
Lipoprotein(a). A unique risk factor for atherothrombotic disease.
Loscalzo, J. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.5.672 · Cited by 296
Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.
Harpel, P. C., Gordon, B. R., & Parker, T. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3847 · Cited by 285
Directed Plasminogen Activation at the Surface of Normal and Malignant Cells
(1991) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)61002-7 · Cited by 281
Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.
Cressman, M. D., Heyka, R. J., Paganini, E. P., O'Neil, J., Skibinski, C. I., & Hoff, H. F. (1992) · Circulation · doi:10.1161/01.cir.86.2.475 · Cited by 281
Lipoprotein(a) and Atherosclerosis
Scanu, A. M., Lawn, R. M., & Berg, K. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-209 · Cited by 276
Self-citationKraft, H. G., Menzel, H. J., Hoppichler, F., Vogel, W., & Utermann, G. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113849 · Cited by 263
Harpel, P. C., Chang, V. T., & Borth, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10193 · Cited by 259
Bostom, A. G., Gagnon, D. R., Cupples, L. A., Wilson, P. W., Jenner, J. L., Ordovas, J. M., Schaefer, E. J., & Castelli, W. P. (1994) · Circulation · doi:10.1161/01.cir.90.4.1688 · Cited by 255
Gaubatz, J., Ghanem, K., Guevara, J., Nava, M., Patsch, W., & Morrisett, J. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42828-7 · Cited by 253
From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk
Shapiro, M. D., & Fazio, S. (2016) · Circulation Research · doi:10.1161/circresaha.115.306471 · Cited by 217
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.
Rader, D. J., Mann, W. A., Cain, W., Kraft, H. G., Usher, D., Zech, L. A., Hoeg, J. M., Davignon, J., Lupien, P., & Grossman, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117794 · Cited by 176
Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects
Knight, B. L., Perombelon, Y. F. N., Soutar, A. K., Wade, D. P., & Seed, M. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90025-x · Cited by 78
Shapiro, M. D., Minnier, J., Tavori, H., Kassahun, H., Flower, A., Somaratne, R., & Fazio, S. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010932 · Cited by 70
Rainwater, D. L., McMahan, C. A., Malcom, G. T., Scheer, W. D., Roheim, P. S., McGill, H. C., & Strong, J. P. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.753 · Cited by 62
Metadata
- Authors
- Eaton, D. L., Fless, G. M., Kohr, W. J., McLean, J. W., Xu, Q. T., Miller, C. G., Lawn, R. M., & Scanu, A. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1987-05
- Volume
- 84
- Issue
- 10
- Pages
- 3224-3228
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2083516336
- Cited by
- 416
- References
- 25
- FWCI
- 37.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.